
    
      A randomised, double-blind, multinational, multicentre, active-controlled, 3-way cross-over
      study to evaluate the effect on trough FEV1 after 4 weeks treatment with CHF5188 pMDI qd in
      adult patients with moderate or severe persistent asthma
    
  